Akebia Therapeutics (AKBA) Shares Outstanding (Diluted) (2017 - 2026)
Akebia Therapeutics (AKBA) reported Shares Outstanding (Diluted) of 269.6 million for Q2 2026, down 0.6% from 271.1 million a year earlier but up 1.0% from the prior quarter.
Powered by 
Analysis
Akebia Therapeutics (AKBA) Shares Outstanding (Diluted) (2017 - 2026) Analysis & Trends
For FY2025, Akebia Therapeutics posted Shares Outstanding (Diluted) of 257.16 million, up 21.9% from FY2024.
- Shares Outstanding (Diluted) has increased for seven consecutive years, with a five-year compound annual growth rate of 13.2% (FY2020 to FY2025).
- By year, Shares Outstanding (Diluted) came in at 210.95 million in FY2024 (+12.5%), 187.47 million in FY2023 (+2.6%), 182.78 million in FY2022 (+10.1%) and 165.95 million in FY2021 (+19.9%).
- Five-year quarterly Shares Outstanding (Diluted) spans a low of 165.95 million in Q4 2021 and a high of 274.37 million in Q3 2025.
- Year over year, Shares Outstanding (Diluted) gained in seven of the last eight quarters, with growth averaging 16.7%.
- The high point for year-over-year Shares Outstanding (Diluted) in five years was Q3 2025 (growth of 30.4%); the low point was Q2 2023 (a decline of 1.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at 267.05 million (Q1 2026), 257.16 million (Q4 2025) and 274.37 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.44 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.96 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.56 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 544.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 255.20 Mn |
| 10 | Akebia Therapeutics | 250.00 Mn | -419.48 Mn | 38.70 Mn | 269.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 269.60 Mn |
| Mar 31, 2026 | 267.05 Mn |
| Dec 31, 2025 | 257.16 Mn |
| Sep 30, 2025 | 274.37 Mn |
| Jun 30, 2025 | 271.10 Mn |
| Mar 31, 2025 | 241.60 Mn |
| Dec 31, 2024 | 210.95 Mn |
| Sep 30, 2024 | 210.35 Mn |
| Jun 30, 2024 | 209.71 Mn |
| Mar 31, 2024 | 204.96 Mn |
| Dec 31, 2023 | 187.47 Mn |
| Sep 30, 2023 | 188.31 Mn |
| Jun 30, 2023 | 186.82 Mn |
| Mar 31, 2023 | 184.77 Mn |
| Dec 31, 2022 | 182.78 Mn |
| Sep 30, 2022 | 183.88 Mn |
| Jun 30, 2022 | 190.38 Mn |
| Mar 31, 2022 | 179.60 Mn |
| Dec 31, 2021 | 165.95 Mn |
| Sep 30, 2021 | 173.78 Mn |
API Access
Akebia Therapeutics Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=AKBA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "AKBA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=AKBA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();